Additionally, deletion of CDKN1C has been shown to improve human islet function (Avrahami et al., 2014) and gain-of-function mutants are associated with diabetes development and hyperinsulinism (Kerns et al., 2014; Brioude et al., 2015). Here, CDKN1C is linked to diabetes mellitus.